A 12-Week Safety and Pharmacodynamic Study of AT1001 (Migalastat Hydrochloride) in Participants With Fabry Disease
Clinical trial NCT00283959 · COMPLETED
Trial details
- NCT number
- NCT00283959
- Sponsor
- Amicus Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-06-27
- Primary completion
- 2008-05-08
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.